Endocrinology, Diabetes & Metabolism Doctors in Greenbrae, CA Accepting Medicare

4 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 4

Se Young Suh, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 900 S Eliseo Dr Ste 201, Greenbrae, CA 94904 Phone: 415-461-1780

Linda Marie Gaudiani, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 900 South Eliseo Dr, Ste 201, Greenbrae, CA 94904 Phone: 415-461-1780    Fax: 415-461-7378

Richard Ira Bernstein, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 900 South Eliseo Dr, #201, Greenbrae, CA 94904 Phone: 415-461-1780    Fax: 415-461-7378

Dr. Alexander Vogel Uihlein, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 900 S Eliseo Dr Ste 201, Greenbrae, CA 94904 Phone: 415-461-1780    Fax: 415-461-7378

News Archive

Research shows how bacteria associated with Crohn's disease tolerate antibiotics

Bacteria associated with Crohn's disease rely on multiple stress responses to survive, multiply, and tolerate antibiotics within white blood cells called macrophages, according to a study published November 14 in the open-access journal PLOS Pathogens by Olivier Espéli of the College de France and PSL Research University in Paris, France, and colleagues.

'Small intestinal permeable peptides' improve biopharmaceuticals absorption in digestive tract

Biopharmaceuticals, medium- and high-molecular weight biologically active macromolecules, are not easily absorbed by the small intestine, the main organ responsible for gastrointestinal absorption, resulting in a bottleneck for oral administration type biopharmaceutical development.

New clinical trial to compare effectiveness of injectable drugs and oral medications to treat HIV

Researchers at the University of Colorado Anschutz Medical Campus, working with the National Institutes of Health, will conduct a clinical trial beginning this month to determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills in a population for whom daily adherence has been a challenge.

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has classified the OFIRMEV™ (acetaminophen) injection New Drug Application (NDA) resubmission as a complete Class 2 response to the FDA's February 10, 2010 action letter and assigned a new Prescription Drug User Fee Act (PDUFA) action date of November 4, 2010.

Study: Government anti-drinking campaigns irrelevant to young binge drinkers

Government advertising campaigns to tackle excessive drinking are dismissed as irrelevant by young binge drinkers, because consuming extreme quantities of alcohol is part of their sub-cultural social identity, according to research published this week (18th March) in the Journal of Business Research.

Read more Medical News

› Verified 8 days ago